Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1981 1
1983 1
1988 1
1990 1
1991 4
1992 1
1993 2
1994 4
1995 3
1996 5
1997 5
1998 5
1999 3
2000 5
2001 5
2002 1
2003 5
2004 10
2005 6
2006 6
2007 5
2008 13
2009 16
2010 6
2011 11
2012 14
2013 14
2014 14
2015 14
2016 9
2017 7
2018 13
2019 9
2020 13
2021 13
2022 11
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

233 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Resectable Pleural Malignant Mesothelioma"
Page 1
Updates in Management of Malignant Pleural Mesothelioma.
John A, O'Sullivan H, Popat S. John A, et al. Curr Treat Options Oncol. 2023 Dec;24(12):1758-1789. doi: 10.1007/s11864-023-01148-2. Epub 2023 Nov 17. Curr Treat Options Oncol. 2023. PMID: 37975977 Review.
Malignant pleural mesothelioma (MPM) is an aggressive asbestos-associated thoracic malignancy that is usually incurable. As demonstrated in the landmark MARS2 trial, surgical resection does not improve survival outcomes and its role in managing …
Malignant pleural mesothelioma (MPM) is an aggressive asbestos-associated thoracic malignancy that is usually incurable …
Peritoneal mesothelioma.
Hesdorffer ME, Chabot J, DeRosa C, Taub R. Hesdorffer ME, et al. Curr Treat Options Oncol. 2008 Jun;9(2-3):180-90. doi: 10.1007/s11864-008-0072-2. Epub 2008 Oct 8. Curr Treat Options Oncol. 2008. PMID: 18841478 Review.
Malignant peritoneal mesothelioma (MPM) is an aggressive neoplasm that rapidly spreads within the confines of the abdominal cavity to involve most accessible peritoneal and omental surfaces. ...Unless referred to a specialty center, patients are routinely treated wi …
Malignant peritoneal mesothelioma (MPM) is an aggressive neoplasm that rapidly spreads within the confines of the abdominal ca …
Pericardial mesothelioma.
Vigneswaran WT, Stefanacci PR. Vigneswaran WT, et al. Curr Treat Options Oncol. 2000 Oct;1(4):299-302. doi: 10.1007/s11864-000-0045-6. Curr Treat Options Oncol. 2000. PMID: 12057155 Review.
Surgical resection remains the main treatment modality. When the disease is localized and completely resected, long-term survival can result. ...Addition of chemotherapy or radiation has been disappointing. Newer therapeutic approaches for malignant pleura …
Surgical resection remains the main treatment modality. When the disease is localized and completely resected, long-term survi …
Peritoneal mesothelioma.
Taub RN, Keohan ML, Chabot JC, Fountain KS, Plitsas M. Taub RN, et al. Curr Treat Options Oncol. 2000 Oct;1(4):303-12. doi: 10.1007/s11864-000-0046-5. Curr Treat Options Oncol. 2000. PMID: 12057156 Review.
Malignant peritoneal mesothelioma is an aggressive neoplasm that rapidly spreads within the confines of the abdominal cavity to involve most accessible peritoneal and omental surfaces. ...Our current experimental regimen includes initial laparotomy with omentectomy, …
Malignant peritoneal mesothelioma is an aggressive neoplasm that rapidly spreads within the confines of the abdominal cavity t …
Pleural mesothelioma: is the surgeon still there?
Opitz I, Weder W. Opitz I, et al. Ann Oncol. 2018 Aug 1;29(8):1710-1717. doi: 10.1093/annonc/mdy195. Ann Oncol. 2018. PMID: 29905765 Free article. Review.
Malignant pleural mesothelioma (MPM) is a rare malignancy with some unique characteristics. ...Despite more knowledge on histology, tumor biology and staging, there is still a relevant discrepancy between clinical and pathologic staging resulting in di …
Malignant pleural mesothelioma (MPM) is a rare malignancy with some unique characteristics. ...Despite more knowledge o …
Induction Therapy for Mesothelioma.
Opitz I, Weder W. Opitz I, et al. Semin Thorac Cardiovasc Surg. 2015 Summer;27(2):240-9. doi: 10.1053/j.semtcvs.2015.05.003. Epub 2015 Jun 17. Semin Thorac Cardiovasc Surg. 2015. PMID: 26686455 Review.
One particular approach of multimodality treatment for mesothelioma is induction therapy followed by surgery. Among its several advantages, the most important is downstaging of the tumor into a resectable stage, although morbidity and mortality might be increased. I …
One particular approach of multimodality treatment for mesothelioma is induction therapy followed by surgery. Among its several advan …
Malignant pleural mesothelioma.
Boutin C, Schlesser M, Frenay C, Astoul P. Boutin C, et al. Eur Respir J. 1998 Oct;12(4):972-81. doi: 10.1183/09031936.98.12040972. Eur Respir J. 1998. PMID: 9817178 Free article. Review.
The incidence of malignant pleural mesothelioma (MPM) has risen for some decades and is expected to peak between 2010 and 2020. ...Palliative treatment is indicated for stage IV. In any case, each patient should be enrolled in a clinical trial.. …
The incidence of malignant pleural mesothelioma (MPM) has risen for some decades and is expected to peak between 2010 a …
Local and systemic therapies for malignant pleural mesothelioma.
Gomez D, Tsao AS. Gomez D, et al. Curr Treat Options Oncol. 2014 Dec;15(4):683-99. doi: 10.1007/s11864-014-0314-4. Curr Treat Options Oncol. 2014. PMID: 25266654 Review.
Malignant pleural mesothelioma (MPM) is a challenging disease to treat with median overall survival times ranging between 9-17 months for all stages of disease. Recent clinical trials have improved our understanding of the biology of MPM. ...
Malignant pleural mesothelioma (MPM) is a challenging disease to treat with median overall survival times ranging betwe …
Multimodal management of malignant pleural mesothelioma: where are we today?
Van Schil PE, Opitz I, Weder W, De Laet C, Domen A, Lauwers P, Hendriks JM, Van Meerbeeck JP. Van Schil PE, et al. Eur Respir J. 2014 Sep;44(3):754-64. doi: 10.1183/09031936.00207213. Epub 2014 Feb 13. Eur Respir J. 2014. PMID: 24525443 Free article.
The prognosis of patients with malignant pleural mesothelioma remains poor and although it is clear that multimodal therapy is necessary to improve long-term results, precise treatment schemes have not yet been unequivocally established. ...Due to the relativ …
The prognosis of patients with malignant pleural mesothelioma remains poor and although it is clear that multimodal the …
Photodynamic therapy for lung cancer and malignant pleural mesothelioma.
Simone CB 2nd, Cengel KA. Simone CB 2nd, et al. Semin Oncol. 2014 Dec;41(6):820-30. doi: 10.1053/j.seminoncol.2014.09.017. Epub 2014 Oct 7. Semin Oncol. 2014. PMID: 25499640 Free PMC article. Review.
PDT can be used in advanced NSCLC to attempt to increase operability or to reduce the extent of operation intervention required, and selectively to treat pleural dissemination intraoperatively following macroscopically complete surgical resection. Intraoperative PDT …
PDT can be used in advanced NSCLC to attempt to increase operability or to reduce the extent of operation intervention required, and selecti …
233 results